Age- and sex-specific distribution of prevalence, incidence, mortality, and DALY rates for leukemia in mainland China. حسب Yu Fu (16582)

الموضوعات:

Projections of mortality for hematological malignancies in mainland China. حسب Yu Fu (16582)

الموضوعات:

Fig 5 - حسب Wenqi Zhang (2953815)

الموضوعات:

Net change of total cultivated land area in various regions of China since the 21st century (km²). حسب Wenqi Zhang (2953815)

الموضوعات:

Changing area of cultivated land loss in China during 2000–2020 (km²). حسب Wenqi Zhang (2953815)

الموضوعات:

Changing area of cultivated land expansion in China during 2000–2020 (km²). حسب Wenqi Zhang (2953815)

الموضوعات:

Spatial characteristics of cultivated land loss in China during 2000~2020. حسب Wenqi Zhang (2953815)

الموضوعات:

Spatial characteristics of cultivated land expansion in China during 2000~2020. حسب Wenqi Zhang (2953815)

الموضوعات:

Regional division of China. حسب Wenqi Zhang (2953815)

الموضوعات:

Fig 4 - حسب Wenqi Zhang (2953815)

الموضوعات:

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Primary and secondary efficacy end points (intention-to-treat population). حسب Benjamin R. Lewis (22279166)

الموضوعات:

Demographic and clinical characteristics of participants at baseline. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Study-related adverse events. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Study flow chart. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Study CONSORT diagram. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Change in Demoralization Scale (DSII) by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Negative ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5). حسب Peng-fei Han (694841)